LongRiver Investments

Asia, Shanghai, China, Xuhui

Description

LRI Jiangyuan Investment continues to focus on the medical and technology fields.

Investor Profile

LongRiver Investments has made 10 investments, with 5 in the past 12 months and 40% as lead.

Stage Focus

Series B (50%)
Series A (30%)
Seed (20%)

Country Focus

China (60%)
United States (30%)

Industry Focus

Health Care
Biotechnology
Medical
Therapeutics
Medical Device
Robotics
Pharmaceutical
App Discovery
Data Center
Devops

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LongRiver Investments frequently co-invest with?

Kington Capital

Asia, Jiangsu, China, Suzhou

Co-Investments: 1

Boyuan Capital

Asia, Shanghai, China, Shanghai

Co-Investments: 1

Qingsong Capital

Asia, Beijing, China, Beijing

Co-Investments: 1

Matrix Partners China

Asia, Beijing, China, Beijing

Co-Investments: 2

Vivo Capital

North America, California, United States, Palo Alto

Co-Investments: 2

Nanshan War Xintou

Asia, Hunan, China, Nanshan

Co-Investments: 1

GGV Capital

North America, California, United States, Menlo Park

Co-Investments: 2

Lilly Asia Ventures

Asia, Shanghai, China, Shanghai

Co-Investments: 3

What are some of recent deals done by LongRiver Investments?

Rona Therapeutics

Shanghai, Shanghai, China

Rona Therapeutics is a RNA therapeutics platform enabling discovery, development of modular and programmable RNA medicines.

BiotechnologyHealth CareMedicalTherapeutics

Series BMar 14, 2025

Amount Raised: $25,000,000

Oukejian

Nanshan, Hunan, China

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

BiotechnologyHealth CareMedical

Series AJan 13, 2025

Amount Raised: $13,641,076

Ouro Medicines

San Francisco, California, United States

Ouroboros Medicines is a biotechnology company specializes in immunology.

BiotechnologyHealth CareMedical

Series AJan 10, 2025

Amount Raised: $120,000,000

Zhilong New Materials

Zhongshan, Anhui, China

Zhilong New Materials is a Sino-foreign joint venture semiconductor material innovation enterprise.

Advanced MaterialsPrecious MetalsSemiconductor

Series ADec 31, 2024

Henghui Keyuan

Henghui Keyuan is the next generation of disruptors in the electrochemical energy storage battery business.

BatteryEnergy Storage

SeedDec 9, 2024

Ronovo Surgical

Shanghai, Shanghai, China

Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.

Health CareMedical DeviceRobotics

Series BAug 30, 2023

Amount Raised: $27,455,179

Allorion Therapeutics

Natick, Massachusetts, United States

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

MedicalPharmaceuticalTherapeutics

Series BMar 9, 2023

Amount Raised: $50,000,000

Ronovo Surgical

Shanghai, Shanghai, China

Ronovo Surgical is an emerging medtech company focused on innovating minimally invasive (MIS) and digital surgery.

Health CareMedical DeviceRobotics

Series BDec 21, 2022

Sironax

Beijing, Beijing, China

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics

Series BAug 2, 2022

Amount Raised: $200,000,000

Device42

West Haven, Connecticut, United States

Device42 is a provider of hybrid IT discovery and application dependency mapping software.

App DiscoveryData CenterDevOpsInformation TechnologyIT InfrastructureSoftware

SeedJan 6, 2015

Amount Raised: $1,000,000

LongRiver Investments

Description

Investor Profile

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does LongRiver Investments frequently co-invest with?

What are some of recent deals done by LongRiver Investments?

Ready to Raise Capital?

Pages

Free tools